{"id":"https://openalex.org/W4403510752","doi":"https://doi.org/10.1021/acs.jmedchem.4c01221","title":"Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors","display_name":"Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors","alternate_titles":[],"publication_year":2024,"publication_date":"2024-10-17","ids":{"openalex":"https://openalex.org/W4403510752","doi":"https://doi.org/10.1021/acs.jmedchem.4c01221","pmid":"https://pubmed.ncbi.nlm.nih.gov/39418396"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.4c01221","doi":"https://doi.org/10.1021/acs.jmedchem.4c01221","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.4c01221","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4403510752"],"child_works_count":4,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047674059","display_name":"Yuting Qin","orcid":"https://orcid.org/0009-0002-6692-8648","observed_orcids":["https://orcid.org/0009-0002-6692-8648"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yuting Qin","raw_affiliation_strings":["Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark"],"raw_orcid":"https://orcid.org/0009-0002-6692-8648","affiliations":[{"raw_affiliation_string":"Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084915515","display_name":"Cecilie Poulsen","orcid":"https://orcid.org/0009-0002-4511-9251","observed_orcids":["https://orcid.org/0009-0002-4511-9251"]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cecilie Poulsen","raw_affiliation_strings":["Department of Biomedicine, Faculty of Health, Aarhus University, 8000 Aarhus C, Denmark"],"raw_orcid":"https://orcid.org/0009-0002-4511-9251","affiliations":[{"raw_affiliation_string":"Department of Biomedicine, Faculty of Health, Aarhus University, 8000 Aarhus C, Denmark","institution_ids":["https://openalex.org/I204337017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018575749","display_name":"Dilip Narayanan","orcid":"https://orcid.org/0000-0001-9164-9961","observed_orcids":["https://orcid.org/0000-0001-9164-9961"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dilip Narayanan","raw_affiliation_strings":["Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019936011","display_name":"Camilla B. Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2801134892","display_name":"Novo Nordisk Foundation","ror":"https://ror.org/04txyc737","country_code":"DK","type":"facility","lineage":["https://openalex.org/I2801134892"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Camilla B. Chan","raw_affiliation_strings":["Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark","Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]},{"raw_affiliation_string":"Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2801134892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101910830","display_name":"Xiangrong Chen","orcid":"https://orcid.org/0000-0003-0587-3444","observed_orcids":["https://orcid.org/0000-0003-0587-3444"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiangrong Chen","raw_affiliation_strings":["Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107615900","display_name":"Beatriz Ralsi Montes","orcid":"https://orcid.org/0009-0003-3263-0883","observed_orcids":["https://orcid.org/0009-0003-3263-0883"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Beatriz Ralsi Montes","raw_affiliation_strings":["Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K"],"raw_orcid":"https://orcid.org/0009-0003-3263-0883","affiliations":[{"raw_affiliation_string":"Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114054385","display_name":"Kim T. Tran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kim T. Tran","raw_affiliation_strings":["Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001772631","display_name":"Elina Mukminova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elina Mukminova","raw_affiliation_strings":["Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019928832","display_name":"Chun\u2010Yu Lin","orcid":"https://orcid.org/0000-0002-6818-4681","observed_orcids":["https://orcid.org/0000-0002-6818-4681"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chunyu Lin","raw_affiliation_strings":["Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000797815","display_name":"Michael Gajhede","orcid":"https://orcid.org/0000-0001-9864-2287","observed_orcids":["https://orcid.org/0000-0001-9864-2287"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Gajhede","raw_affiliation_strings":["Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark"],"raw_orcid":"https://orcid.org/0000-0001-9864-2287","affiliations":[{"raw_affiliation_string":"Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078379938","display_name":"Alex N. Bullock","orcid":"https://orcid.org/0000-0001-6757-0436","observed_orcids":["https://orcid.org/0000-0001-6757-0436"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alex N. Bullock","raw_affiliation_strings":["Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K"],"raw_orcid":"https://orcid.org/0000-0001-6757-0436","affiliations":[{"raw_affiliation_string":"Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000811036","display_name":"David P. Olagnier","orcid":"https://orcid.org/0000-0001-6912-0674","observed_orcids":["https://orcid.org/0000-0001-6912-0674"]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Olagnier","raw_affiliation_strings":["Department of Biomedicine, Faculty of Health, Aarhus University, 8000 Aarhus C, Denmark"],"raw_orcid":"https://orcid.org/0000-0001-6912-0674","affiliations":[{"raw_affiliation_string":"Department of Biomedicine, Faculty of Health, Aarhus University, 8000 Aarhus C, Denmark","institution_ids":["https://openalex.org/I204337017"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059275377","display_name":"Anders Bach","orcid":"https://orcid.org/0000-0003-4305-9910","observed_orcids":["https://orcid.org/0000-0003-4305-9910"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anders Bach","raw_affiliation_strings":["Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark"],"raw_orcid":"https://orcid.org/0000-0003-4305-9910","affiliations":[{"raw_affiliation_string":"Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5059275377"],"corresponding_institution_ids":["https://openalex.org/I124055696"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.2798,"has_fulltext":false,"cited_by_count":24,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90056011,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"67","issue":"21","first_page":"18828","last_page":"18864"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11332","display_name":"Genomics, phytochemicals, and oxidative stress","score":0.9580000042915344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11332","display_name":"Genomics, phytochemicals, and oxidative stress","score":0.9580000042915344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.010700000450015068,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/keap1-nrf2-interaction","display_name":"Keap1-Nrf2 interaction","score":0.871999979019165},{"id":"https://openalex.org/keywords/protein-protein-interaction-inhibitors","display_name":"protein-protein interaction inhibitors","score":0.8519999980926514},{"id":"https://openalex.org/keywords/tetrahydroisoquinolines","display_name":"tetrahydroisoquinolines","score":0.9020000100135803},{"id":"https://openalex.org/keywords/conformational-restriction","display_name":"conformational restriction","score":0.9509999752044678},{"id":"https://openalex.org/keywords/fluorenone-derivatives","display_name":"fluorenone derivatives","score":0.8109999895095825},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.6140000224113464},{"id":"https://openalex.org/keywords/metabolic-stability","display_name":"metabolic stability","score":0.6140000224113464},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.5210000276565552},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.7039999961853027},{"id":"https://openalex.org/keywords/fragment-based-drug-discovery","display_name":"fragment-based drug discovery","score":0.7829999923706055},{"id":"https://openalex.org/keywords/cellular-activity","display_name":"cellular activity","score":0.43299999833106995}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9333102703094482},{"id":"https://openalex.org/C2776406546","wikidata":"https://www.wikidata.org/wiki/Q411677","display_name":"Tetrahydroisoquinoline","level":2,"score":0.767656147480011},{"id":"https://openalex.org/C137277065","wikidata":"https://www.wikidata.org/wiki/Q2915446","display_name":"Non-covalent interactions","level":4,"score":0.47927945852279663},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.46201956272125244},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4238182604312897},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.38877052068710327},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3085225820541382},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.18354803323745728},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.13965365290641785},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.13297423720359802},{"id":"https://openalex.org/C112887158","wikidata":"https://www.wikidata.org/wiki/Q169324","display_name":"Hydrogen bond","level":3,"score":0.10923153162002563}],"mesh":[{"descriptor_ui":"D000072019","descriptor_name":"Kelch-Like ECH-Associated Protein 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000072019","descriptor_name":"Kelch-Like ECH-Associated Protein 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008968","descriptor_name":"Molecular Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D051267","descriptor_name":"NF-E2-Related Factor 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051267","descriptor_name":"NF-E2-Related Factor 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1021/acs.jmedchem.4c01221","doi":"https://doi.org/10.1021/acs.jmedchem.4c01221","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.4c01221","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:39418396","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39418396","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/387a735d-e04a-40d0-886f-84a70468db4e","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/387a735d-e04a-40d0-886f-84a70468db4e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Qin, Y, Poulsen, C, Narayanan, D, Chan, C B, Chen, X, Montes, B R, Tran, K T, Mukminova, E, Lin, C, Gajhede, M, Bullock, A N, Olagnier, D & Bach, A 2024, 'Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors', Journal of Medicinal Chemistry, vol. 67, no. 21, pp. 18828\u201318864. https://doi.org/10.1021/acs.jmedchem.4c01221","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:publications/07456ebc-ce82-4805-a0a8-86cda1db7e30","doi":null,"is_oa":false,"landing_page_url":"https://pure.au.dk/portal/en/publications/07456ebc-ce82-4805-a0a8-86cda1db7e30","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Qin, Y, Poulsen, C, Narayanan, D, Chan, C B, Chen, X, Montes, B R, Tran, K T, Mukminova, E, Lin, C, Gajhede, M, Bullock, A N, Olagnier, D & Bach, A 2024, 'Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors', Journal of Medicinal Chemistry, vol. 67, no. 21, pp. 18828-18864. https://doi.org/10.1021/acs.jmedchem.4c01221","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1049015016","display_name":null,"funder_award_id":"R77-A6742","funder_id":"https://openalex.org/F4320321999","funder_display_name":"Lundbeckfonden"},{"id":"https://openalex.org/G1763645630","display_name":null,"funder_award_id":"R335\u20102019\u20102138","funder_id":"https://openalex.org/F4320321999","funder_display_name":"Lundbeckfonden"},{"id":"https://openalex.org/G2003881057","display_name":null,"funder_award_id":"875510","funder_id":"https://openalex.org/F4320326631","funder_display_name":"Innovative Medicines Initiative"},{"id":"https://openalex.org/G3667742322","display_name":null,"funder_award_id":"202009370089","funder_id":"https://openalex.org/F4320322725","funder_display_name":"China Scholarship Council"},{"id":"https://openalex.org/G4100904719","display_name":null,"funder_award_id":"10-085264","funder_id":"https://openalex.org/F4320322928","funder_display_name":"Danmarks Frie Forskningsfond"},{"id":"https://openalex.org/G5203734647","display_name":"MAX IV operations \u2013 Formas","funder_award_id":"2019-02496","funder_id":"https://openalex.org/F4320321033","funder_display_name":"Svenska Forskningsr\u00e5det Formas"},{"id":"https://openalex.org/G7031468586","display_name":null,"funder_award_id":"NNF14CC000","funder_id":"https://openalex.org/F4320325957","funder_display_name":"Novo Nordisk Fonden"},{"id":"https://openalex.org/G7062728469","display_name":null,"funder_award_id":"R366-2021-270","funder_id":"https://openalex.org/F4320321999","funder_display_name":"Lundbeckfonden"},{"id":"https://openalex.org/G826471996","display_name":"MAX IV operations 2019-2021","funder_award_id":"2018-04969","funder_id":"https://openalex.org/F4320321030","funder_display_name":"VINNOVA"},{"id":"https://openalex.org/G8725625592","display_name":null,"funder_award_id":"R279-A16218","funder_id":"https://openalex.org/F4320310455","funder_display_name":"Kr\u00e6ftens Bek\u00e6mpelse"}],"funders":[{"id":"https://openalex.org/F4320310455","display_name":"Kr\u00e6ftens Bek\u00e6mpelse","ror":"https://ror.org/03ytt7k16"},{"id":"https://openalex.org/F4320310761","display_name":"H\u00f8rslev-Fonden","ror":"https://ror.org/02z5ef964"},{"id":"https://openalex.org/F4320313096","display_name":"Diamond Light Source","ror":"https://ror.org/05etxs293"},{"id":"https://openalex.org/F4320314178","display_name":"European Federation of Pharmaceutical Industries and Associations","ror":"https://ror.org/00g1x4v36"},{"id":"https://openalex.org/F4320321030","display_name":"VINNOVA","ror":"https://ror.org/01kd5m353"},{"id":"https://openalex.org/F4320321033","display_name":"Svenska Forskningsr\u00e5det Formas","ror":"https://ror.org/03pjs1y45"},{"id":"https://openalex.org/F4320321999","display_name":"Lundbeckfonden","ror":"https://ror.org/03hz8wd80"},{"id":"https://openalex.org/F4320322509","display_name":"Kungliga Tekniska H\u00f6gskolan","ror":"https://ror.org/026vcq606"},{"id":"https://openalex.org/F4320322725","display_name":"China Scholarship Council","ror":"https://ror.org/04atp4p48"},{"id":"https://openalex.org/F4320322928","display_name":"Danmarks Frie Forskningsfond","ror":"https://ror.org/02sptwz63"},{"id":"https://openalex.org/F4320323862","display_name":"Eva og Henry Fr\u00e6nkels Mindefond","ror":"https://ror.org/04wf7sx08"},{"id":"https://openalex.org/F4320325957","display_name":"Novo Nordisk Fonden","ror":"https://ror.org/04txyc737"},{"id":"https://openalex.org/F4320326102","display_name":"Hartmann Fonden","ror":"https://ror.org/05t3dfy66"},{"id":"https://openalex.org/F4320326367","display_name":"Fabrikant Einar Willumsens Mindelegat","ror":null},{"id":"https://openalex.org/F4320326631","display_name":"Innovative Medicines Initiative","ror":"https://ror.org/019af4n30"},{"id":"https://openalex.org/F4320332999","display_name":"Horizon 2020 Framework Programme","ror":"https://ror.org/00k4n6c32"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W598738849","https://openalex.org/W1166587220","https://openalex.org/W1421415727","https://openalex.org/W1738379757","https://openalex.org/W1916286037","https://openalex.org/W1991631628","https://openalex.org/W2037690163","https://openalex.org/W2081771891","https://openalex.org/W2086937283","https://openalex.org/W2095453782","https://openalex.org/W2098167941","https://openalex.org/W2110232651","https://openalex.org/W2124026197","https://openalex.org/W2125762200","https://openalex.org/W2132477542","https://openalex.org/W2154151379","https://openalex.org/W2154197653","https://openalex.org/W2163341755","https://openalex.org/W2237391427","https://openalex.org/W2313095031","https://openalex.org/W2327865165","https://openalex.org/W2525470835","https://openalex.org/W2573662277","https://openalex.org/W2590224536","https://openalex.org/W2766716573","https://openalex.org/W2800106920","https://openalex.org/W2801290128","https://openalex.org/W2801429717","https://openalex.org/W2907855283","https://openalex.org/W2936890006","https://openalex.org/W2957095122","https://openalex.org/W2967882385","https://openalex.org/W2977696708","https://openalex.org/W2986733785","https://openalex.org/W2991943959","https://openalex.org/W3009220429","https://openalex.org/W3015784228","https://openalex.org/W3024952389","https://openalex.org/W3047494539","https://openalex.org/W3081641281","https://openalex.org/W3082000792","https://openalex.org/W3084189106","https://openalex.org/W3141236967","https://openalex.org/W3150076228","https://openalex.org/W3172576792","https://openalex.org/W3173948537","https://openalex.org/W3204721296","https://openalex.org/W3211168011","https://openalex.org/W4200025979","https://openalex.org/W4223416045","https://openalex.org/W4225693723","https://openalex.org/W4248872320","https://openalex.org/W4295095218","https://openalex.org/W4306874784","https://openalex.org/W4311904534","https://openalex.org/W4313825915","https://openalex.org/W4319460384","https://openalex.org/W4378802575","https://openalex.org/W4380852797","https://openalex.org/W4384030306","https://openalex.org/W4387675884","https://openalex.org/W4393346501"],"related_works":["https://openalex.org/W4413370978","https://openalex.org/W2327865165","https://openalex.org/W3040191986","https://openalex.org/W2595332261","https://openalex.org/W2936890006","https://openalex.org/W4387675884","https://openalex.org/W2018918340","https://openalex.org/W4224092977","https://openalex.org/W3012311210","https://openalex.org/W4384155539"],"abstract_inverted_index":{"Inhibition":[0],"of":[1,37,47,93,135,144,150],"the":[2,66,80,123,128,142,148],"protein\u2013protein":[3],"interaction":[4],"between":[5],"Kelch-like":[6],"ECH-associated":[7],"protein":[8],"1":[9],"(Keap1)":[10],"and":[11,65,76,115,152],"nuclear":[12],"factor":[13,16],"erythroid":[14],"2-related":[15],"2":[17],"(Nrf2)":[18],"has":[19],"been":[20],"recognized":[21],"as":[22],"an":[23],"attractive":[24],"approach":[25],"for":[26,127],"treating":[27],"oxidative":[28],"stress-related":[29],"diseases.":[30],"Here,":[31],"we":[32],"present":[33],"a":[34,43,90,133],"new":[35,91],"series":[36,92],"noncovalent":[38],"Keap1-Nrf2":[39,155],"inhibitors":[40,96],"developed":[41],"by":[42,53,61],"conformational":[44],"restriction":[45],"strategy":[46],"our":[48],"fluorenone-based":[49],"compounds":[50,124],"previously":[51],"identified":[52],"fragment-based":[54],"drug":[55],"discovery.":[56],"The":[57],"design":[58,149],"was":[59,119],"guided":[60],"X-ray":[62],"cocrystal":[63],"structures,":[64],"subsequent":[67],"optimization":[68],"process":[69],"aimed":[70],"at":[71],"improving":[72],"affinity,":[73],"cellular":[74,117],"activity,":[75],"metabolic":[77,113],"stability.":[78],"From":[79],"noncyclic":[81],"compound":[82],"7":[83],"(":[84,105],"K":[85,107],"i":[86,108],"=":[87,109],"2.9":[88],"\u03bcM),":[89],"tetrahydroisoquinoline-based":[94],"Keap1":[95,129],"with":[97],"up":[98],"to":[99],"223-fold":[100],"improvement":[101],"in":[102,147],"binding":[103],"affinity":[104],"57,":[106],"13":[110],"nM),":[111],"better":[112],"stability,":[114],"enhanced":[116],"activity":[118],"obtained.":[120],"In":[121],"addition,":[122],"showed":[125],"selectivity":[126],"Kelch":[130],"domain":[131],"across":[132],"panel":[134],"15":[136],"homologous":[137],"proteins.":[138],"We":[139],"thereby":[140],"demonstrate":[141],"utility":[143],"cyclic":[145],"rigidification":[146],"potent":[151],"more":[153],"drug-like":[154],"inhibitors.":[156]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4403510752","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":13}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2024-10-18T00:00:00"}
